Consolidation therapy
patients
multiple myeloma
MM
improve
treatment response
autologous stem cell transplantation
retrospectively analyzed
safety
efficacy
combination regimen
bortezomib
thalidomide
dexamethasone
VTD
consolidation therapy
Japanese
patients
newly diagnosed
MM
VTD
bortezomib
dose
dexamethasone
dose
days
daily oral
thalidomide
dose
neutropenia
thrombocytopenia
documented
patients
drug dose
reduction
cytopenia
case
Peripheral neuropathy
severe
peripheral neuropathy
partial
response
rates
consolidation therapy
Patients
significant
probability
improving
consolidation therapy
consolidation therapy
VTD
regimen
effective
consolidation therapy
treatment
MM
Japanese
population
